ADN Valuation

Add to Watchlist

Advanced Chart

0.000

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

ADN Relative Valuation

ADN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ADN is overvalued; if below, it's undervalued.

Historical Valuation

Advent Technologies Holdings Inc (ADN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.04 is considered Undervalued compared with the five-year average of -10.90. The fair price of Advent Technologies Holdings Inc (ADN) is between 7.35 to 13.60 according to relative valuation methord. Compared to the current price of 3.24 USD , Advent Technologies Holdings Inc is Undervalued By 55.91%.

Relative Value

Fair Zone

7.35-13.60

Current Price：3.24

55.91%

Undervalued

1.08

Trailing

Forward

0.38

EV/EBITDA

Advent Technologies Holdings Inc. (ADN) has a current EV/EBITDA of 0.38. The 5-year average EV/EBITDA is -13.00. The thresholds are as follows: Strongly Undervalued below -50.62, Undervalued between -50.62 and -31.81, Fairly Valued between 5.80 and -31.81, Overvalued between 5.80 and 24.61, and Strongly Overvalued above 24.61. The current Forward EV/EBITDA of 0.38 falls within the Historic Trend Line -Fairly Valued range.

0.44

EV/EBIT

Advent Technologies Holdings Inc. (ADN) has a current EV/EBIT of 0.44. The 5-year average EV/EBIT is -14.46. The thresholds are as follows: Strongly Undervalued below -101.42, Undervalued between -101.42 and -57.94, Fairly Valued between 29.02 and -57.94, Overvalued between 29.02 and 72.50, and Strongly Overvalued above 72.50. The current Forward EV/EBIT of 0.44 falls within the Historic Trend Line -Fairly Valued range.

0.04

Advent Technologies Holdings Inc. (ADN) has a current PS of 0.04. The 5-year average PS is 9.60. The thresholds are as follows: Strongly Undervalued below -19.15, Undervalued between -19.15 and -4.77, Fairly Valued between 23.98 and -4.77, Overvalued between 23.98 and 38.36, and Strongly Overvalued above 38.36. The current Forward PS of 0.04 falls within the Historic Trend Line -Fairly Valued range.

0.31

P/OCF

Advent Technologies Holdings Inc. (ADN) has a current P/OCF of 0.31. The 5-year average P/OCF is -20.96. The thresholds are as follows: Strongly Undervalued below -105.66, Undervalued between -105.66 and -63.31, Fairly Valued between 21.38 and -63.31, Overvalued between 21.38 and 63.73, and Strongly Overvalued above 63.73. The current Forward P/OCF of 0.31 falls within the Historic Trend Line -Fairly Valued range.

0.40

P/FCF

Advent Technologies Holdings Inc. (ADN) has a current P/FCF of 0.40. The 5-year average P/FCF is -3.93. The thresholds are as follows: Strongly Undervalued below -17.21, Undervalued between -17.21 and -10.57, Fairly Valued between 2.71 and -10.57, Overvalued between 2.71 and 9.34, and Strongly Overvalued above 9.34. The current Forward P/FCF of 0.40 falls within the Historic Trend Line -Fairly Valued range.

Advent Technologies Holdings Inc (ADN) has a current Price-to-Book (P/B) ratio of -0.29. Compared to its 3-year average P/B ratio of 0.00 , the current P/B ratio is approximately -6140.80% higher. Relative to its 5-year average P/B ratio of -394.53, the current P/B ratio is about -99.93% higher. Advent Technologies Holdings Inc (ADN) has a Forward Free Cash Flow (FCF) yield of approximately -38.91%. Compared to its 3-year average FCF yield of -120.23%, the current FCF yield is approximately -67.63% lower. Relative to its 5-year average FCF yield of -78.17% , the current FCF yield is about -50.22% lower.

-0.29

P/B

Median3y

0.00

Median5y

-394.53

-35.25

FCF Yield

Median3y

-120.23

Median5y

-78.17

Performance Decomposition

Market capitalization of ADN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of ADN in the past 1 year is driven by Unknown.